Literature DB >> 27935809

Assessing and measuring cognitive function in major depressive disorder.

Renee-Marie Ragguett1, Danielle S Cha1,2, Ron Kakar1, Joshua D Rosenblat1,3, Yena Lee1, Roger S McIntyre1,3,4.   

Abstract

Cognitive dysfunction is a major component of major depressive disorder (MDD). No 'gold-standard' tool exists for the assessment of cognitive dysfunction for adults with MDD. The use of measurement-based care to improve treatment outcomes invites the need for a systematic screening, evaluation and measurement tool. The aim herein was to provide a succinct summary of literature documenting clinical implication of cognitive dysfunction in MDD, and a review of available screening, diagnostic and measurement tools for cognitive dysfunction in MDD is provided. We also take the opportunity to introduce a screening tool (ie, the THINC-it tool) targeted at addressing the unmet needs. We found that there are limitations to the current measurement scales; for example, many are not targeted for MDD and not all digitally available tests are free of charge. Furthermore, the spectrum of cognitive dysfunction in MDD is poorly represented by the existing tests and as such, there is a lack of sensitivity in the ability to screen a patient with MDD for a cognitive dysfunction. Recognising and addressing the limitations in the current screening techniques for cognitive dysfunction as well as being presented with the current tools available provides the ability to perform an educated cognitive screening for a patient with MDD. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Mesh:

Year:  2016        PMID: 27935809     DOI: 10.1136/eb-2016-102456

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN: 1362-0347


  3 in total

1.  Neuropsychological predictors of response to cognitive behavioral therapy for posttraumatic stress disorder in persons with severe mental illness.

Authors:  Kim T Mueser; Susan R McGurk; Haiyi Xie; Elisa E Bolton; M Kay Jankowski; Weili Lu; Stanley D Rosenberg; Rosemarie Wolfe
Journal:  Psychiatry Res       Date:  2017-10-06       Impact factor: 3.222

2.  Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression.

Authors:  Weihua Zhang; Na Zhu; Jianbo Lai; Jingjing Liu; Chee H Ng; Jun Chen; Chao Qian; Yanli Du; Chanchan Hu; Jingkai Chen; Jianbo Hu; Zhong Wang; Hetong Zhou; Yi Xu; Yiru Fang; Chuan Shi; Shaohua Hu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-21       Impact factor: 2.570

3.  Assessment of current clinical practices for major depression in Japan using a web-based questionnaire.

Authors:  Hikaru Hori; Kentaro Yamato
Journal:  Neuropsychiatr Dis Treat       Date:  2019-10-01       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.